Exploratory Pilot Study on the Prolonged Use of the ABLE Exoskeleton in Multiple Sclerosis

The goal of this study is to explore the potential clinical benefits of the ABLE Exoskeleton as part of a rehabilitation program in people with multiple sclerosis. The main question it aims to answer is: Can a rehabiliation program with the ABLE Exoskeleton help to mantain the physical and psychosocial health of people with multiple sclerosis? Participants will: * Have a gait training session of 60 min with the exoskeleton once a week for 12 months at the clinic * Have an evaluation (tests and questionnaires) every 3 months at the clinic

NCT Number	NCT06921551
Lead Sponsor	ABLE Human Motion S.L. Collaborators: Fundación Esclerosis Múltiple Madrid (FEMM)
Conditions	Multiple Sclerosis
Enrollment	19 participants
Start Date	2025-04-07
Primary Completion	2026-05-29 (estimated)
Study Completion	2026-05-29 (estimated)
Updated on ClinicalTrials.gov	2026-06-02